What is the long-term outcome of the different subgroups of functional dyspepsia?

Alimentary Pharmacology and Therapeutics

Volumn 18, Issue 2, 2003, Pages 223-229

  Heikkinen, M ^a   Farkkila M ^b  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

GASTROINTESTINAL AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DISEASE CLASSIFICATION; DYSPEPSIA; FEMALE; FOLLOW UP; GASTROSCOPY; GENERAL PRACTITIONER; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PATIENT REFERRAL; PEPTIC ULCER; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; REFLUX ESOPHAGITIS; STATISTICAL ANALYSIS; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; DYSPEPSIA; FAMILY PRACTICE; FEMALE; FOLLOW-UP STUDIES; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE;

EID: 0042128388     PISSN: 02692813     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.2003.01685.x     Document Type: Article

References (32)

1. Bytzer P, Hansen JM, Havelund T, Malchow-Moller A, Schaffalitzky de Muckadell OB. Predicting endoscopic diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol 1996; 8: 359-63.
2. Hansen JM, Bytzer P, Schaffalitzky de Muckadell OB. Management of dyspeptic patients in primary care. Value of the unaided clinical diagnosis and of dyspepsia subgrouping. Scand J Gastroenterol 1998; 3: 799-805.
3. Heikkinen M, Pikkarainen P, Eskelinen M, Julkunen R. GPs' ability to diagnose dyspepsia based only on physical examination and patient history. Scand J Prim Health Care 2000; 18: 99-104.
4. Kagevi I, Löfstedt S, Persson L-G. Endoscopic findings and diagnoses in unselected dyspeptic patients at a primary health care center. Scand J Gastroenterol 1989; 24: 145-50.
5. Klauser AG, Voderholzer WA, Knesewitsch PA, Schindlbeck NE, Muller-Lissner SA. What is behind dyspepsia? Dig Dis Sci 1993; 38: 147-54.
6. Colin-Jones DG, Bloom B, Bodemar G, et al. Management of dyspepsia. Report of a working party. Lancet 1988; 1: 576-9.
7. Talley NJ, Zinsmeister AR, Schleck CD, Melton LJ III. Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology 1992; 102: 1259-68.
8. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993; 105: 1378-86.
9. Chiba N, Bernard L, O'Brien BJ, Goeree R, Hunt RH. A Canadian physician survey of dyspepsia management. Can J Gastroenterol 1998; 1: 83-90.
10. Talley NJ, Colin-Jones D, Koch KL, et al. Functional dyspepsia: a classification with guidelines for diagnosis and management. Working team report. Gastroenterol Int 1991; 4: 145-60.
11. Feldman RA, Deeks JJ, Evans SJW. Multi-laboratory comparison of eight commercially available Helicobacter pylori serology kits. Eur J Clin Microbiol Infect Dis 1995; 14; 428-33.
12. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ III Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc 1990; 65: 1456-79.
13. Drossman DA, Thompson GW, Talley NJ, et al. Identification of sub-groups of functional gastrointestinal disorders. Working team report. Gastroenterol Int 1990; 3: 159-72.
14. Agréus L, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population. Overlap and lack of stability over time. Gastroenterology 1995; 109: 671-80.
15. Westbrook JI, Talley NJ. Empiric clustering of dyspepsia into symptom subgroups: a population-based study. Scand J Gastroenterol 2002; 37: 917-23.
16. Euler AR, Byrne WJ. Twenty-four-hour esophageal intraluminal pH probe testing: a comparative analysis. Gastroenterology 1981; 80: 957-61.
17. Richter JE, Castell DO. Gastroesophageal reflux. Pathogenesis, diagnosis and therapy. Ann Intern Med 1982; 97: 93-103.
18. Kahrilas PJ, Quigley EM. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996; 110: 1982-96.
19. Talley NJ, Stanghellini V, Heading RC, et al. Functional gastroduodenal disorders. Gut 1999; 45(Suppl. II): II37-II42.
20. Agréus L, Svärdsudd K, Talley NJ, Jones MP, Tibblin G. Natural history of gastroesophageal reflux disease and functional abdominal disorders: a population-based study. Am J Gastroenterol 2001; 96: 2905-14.
21. Weir RD, Backett EM. Studies of the epidemiology of peptic ulcer in a rural community: prevalence and natural history of dyspepsia and peptic ulcer. Gut 1968; 9: 75-83.
22. Sloth H, Jørgensen LS. Chronic non-organic upper abdominal pain, diagnostic safety and prognosis of gastrointestinal and non-intestinal symptoms. A 5- to 7-year follow-up study. Scand J Gastroenterol 1988; 23: 1275-80.
23. Barnes RJ, Uff JS, Dent JC, Gear MW, Wilkinson SP. Long-term follow up of patients with gastritis associated with Helicobacter pylori infection. Br J General Pract 1991; 41: 286-8.
24. Lindell GH, Celebioglu F, Graffer HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995; 7: 829-33.
25. Meineche-Schmidt V, Jørgensen T. Investigation and therapy in patients with different types of dyspepsia: a 3 year follow-up study from general practice. Fam Pract 2000; 17: 514-21.
26. Dent J, Brun J, Fendrick AM, et al. An evidence-based appraisal of reflux disease management - the Genval Workshop Report. Gut 1999; 44(Suppl. 2): S1-S16.
27. Rekola KE, Keinänen-Kiukaanniemi S, Takala J. Use of primary health services in sparsely populated country districts by patients with musculoskeletal symptoms: consultations with a physician. J Epidemiol Community Health 1993; 47: 153-7.
28. Hsu P-I, Lai K-H, Lo G-H, et al. Risk factors for ulcer development in patients with non-ulcer dyspepsia: a prospective two year follow up study of 209 patients. Gut 2002; 51: 15-20.
29. Talley NJ, Meineche-Schmidt V, Pare P, et al. Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies). Aliment Pharmacol Ther 1998; 12: 1055-65.
30. Schindlbeck NE, Klauser AG, Berghammer G, Londong W, Muller-Lissner SA. Three year follow up of patients with gastroesophageal reflux disease. Gut 1992; 33: 1016-9.
31. McDougall NI, Johnston BT, Kee F, et al. Natural history of reflux oesophagitis: a 10 year follow up of its effect on patient symptomatology and quality of life. Gut 1996; 38: 481-6.
32. Isolauri J, Luostarinen M, Isolauri E, et al. Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients. Am J Gastroenterol 1997; 92: 37-41.